- Previous Close
67.30 - Open
66.50 - Bid --
- Ask --
- Day's Range
66.10 - 67.20 - 52 Week Range
56.00 - 104.50 - Volume
111,068 - Avg. Volume
174,558 - Market Cap (intraday)
5.667B - Beta (5Y Monthly) 0.14
- PE Ratio (TTM)
45.59 - EPS (TTM)
1.45 - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield 1.50 (2.27%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
90.00
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, Covid-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1974 and is headquartered in Taipei, Taiwan.
www.pbf.com.twRecent News: 1760.TW
View MorePerformance Overview: 1760.TW
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1760.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1760.TW
View MoreValuation Measures
Market Cap
5.67B
Enterprise Value
5.81B
Trailing P/E
45.59
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.79
Price/Book (mrq)
2.95
Enterprise Value/Revenue
2.86
Enterprise Value/EBITDA
14.65
Financial Highlights
Profitability and Income Statement
Profit Margin
6.14%
Return on Assets (ttm)
3.99%
Return on Equity (ttm)
6.50%
Revenue (ttm)
2.03B
Net Income Avi to Common (ttm)
124.52M
Diluted EPS (ttm)
1.45
Balance Sheet and Cash Flow
Total Cash (mrq)
558.37M
Total Debt/Equity (mrq)
37.93%
Levered Free Cash Flow (ttm)
93.15M